Pfizer reviews

While there are some exrtraordinary colleagues, there is staggering mediocrity hiding within a still-bloated organization. Highly bureaucratic and hierarchical, it can be difficult for innovative and dynamic leaders to find their way. It can be exceedingly difficult to move within the organization across functions or divisions. Neither performance management nor talent planning is done particularly well. Despite the rhetoric about world-class science, the company feels as though it has given science backseat for the last decade. Rather trying to innovate growth organically, Pfizer has become purely a deal-making machine. This can be more than a bit demoralizing for those who came to the company to engage scientific discovery with the best; the best scientists, I'm afraid, are elsewhere. The fatigue associated with the constant merging and restructuring and right-sizing is definitely taking its toll on staff.

Too big of a company, that had way to many changes in upper management. People need stability in order to keep the ship moving. Too much change will cause the ship to stray away from the main focus, THE CUSTOMER.